Page last updated: 2024-10-21

vanilmandelic acid and Tourette Syndrome

vanilmandelic acid has been researched along with Tourette Syndrome in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Messiha, FS1
Knopp, W1
Vanecko, S1
O'Brien, V1
Corson, SA1

Other Studies

1 other study available for vanilmandelic acid and Tourette Syndrome

ArticleYear
Haloperidol therapy in Tourette's syndrome: neurophysiological, biochemical and behavioral correlates.
    Life sciences. Pt. 1: Physiology and pharmacology, 1971, Apr-15, Volume: 10, Issue:8

    Topics: Adolescent; Behavior; Catecholamines; Dopamine; Haloperidol; Humans; Male; Norepinephrine; Phenylace

1971